Aviva’s Concentrix CNXC Stock Holding History

Aviva’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,562	Closed	-$593K	–	1061
2022 Q1	$593K	Buy	+3,562	New	+$676K	﹤0.01%	1024

Other funds holding CNXC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aviva's CNXC Position: Q2 2022 in Review

Aviva sold out of Concentrix (CNXC) in Q2 2022, closing a stake of 3,562 shares — an estimated $593K sold.

Aviva first reported a position in CNXC in Q1 2022 and held it in 1 quarter. The position peaked at $593K in Q1 2022. 324 funds tracked by Wall St. Rank hold CNXC as of Q2 2022.

Aviva reported no remaining Concentrix position as of Q2 2022 after selling out during the quarter.
Aviva sold 3,562 Concentrix shares in Q2 2022, an estimated $593K.
Aviva first reported a position in Concentrix in Q1 2022 and held it in 1 quarter.
Aviva's Concentrix position peaked at $593K in Q1 2022.
324 funds tracked by Wall St. Rank held Concentrix as of Q2 2022.

Based on Aviva's 13F filing for Q2 2022, filed 4 Aug 2022.